Views

CrossRef citations to date

Altmetric

Letters to the Editor

Haploidentical hematopoietic stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with refractory or relapsed aggressive non-Hodgkin lymphoma

Xiaofang XiaoDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China;

Haiwen HuangDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China; Correspondence[email protected]

Jia ChenDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China;

Yibin JiangDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China;

Lihong ZhangDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China;

Yang XuDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China; ;Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China;

Ting XuDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China;

Xiaochen ChenDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China;

Caixia LiDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China;

Zhengming JinDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China;

Jia RuanDivision of Hematology and Medical Oncology, Weill Cornell Medical College, New York–Presbyterian Hospital, NY, USACorrespondence[email protected]

Depei WuDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China; ;Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China; Correspondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Ethics approval and consent to participate

The Ethics committee of the First Affiliated Hospital of Soochow University approved the study. We have obtained a written and signed consent to publish this paper from these patients.

Acknowledgements

The authors would like to thank Michael Chen (University of Pennsylvania College of Arts and Sciences, Philadelphia, PA 19104) for critical review of the manuscript. This study was supported by research funding from Six Talent Peaks Project in Jiangsu Province (WSN 020).

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://dx.doi.org/10.1080/10428194.2017.1317096.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Haploidentical hematopoietic stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with refractory or relapsed aggressive non-Hodgkin lymphoma

Information for

Open access

Opportunities

Help and information

Haploidentical hematopoietic stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with refractory or relapsed aggressive non-Hodgkin lymphoma

Ethics approval and consent to participate

Acknowledgements

Potential conflict of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature